Related Experiment Video
Updated: Jun 26, 2026

Chemogenetic Regulation in Reprogrammed Stem Cell-derived Precursor Cells in Treating Neurodegenerative Diseases
Published on: May 2, 2025
Driving treatment for females with X-linked adrenoleukodystrophy
Kathleen M Zackowski1, Gerald V Raymond2, Ali Fatemi3
1Kennedy Krieger Institute, Baltimore, MD, USA; Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, MD, USA; Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Objective:
To compare adult females with X-linked adrenoleukodystrophy to age-matched controls and to evaluate the influence of this pathology on clinical presentation and responsiveness to exercise.
Methods:
14 females with X-linked adrenoleukodystrophy and 12 age-matched controls participated in a pre-post design with a 12-week exercise intervention. Outcome measures include neurological exam; quantitative strength, sensation, and walking measures; pain and quality of life questionnaires, and 3 T imaging for white matter integrity of brain and cervical spinal cord.
Results:
At pre-test, females with X-linked adrenoleukodystrophy were significantly worse than controls in hip strength (flexion p = 0.02, extension p = 0.008), sensation (p < 0.0001), walk speed (Timed 25 ft walk p = 0.006, Timed up and go p = 0.02, walk velocity p = 0.13), pain (p = 0.007), and quality of life (p = 0.01). Significant positive changes are found in post-training for strength (flexion p = 0.03, extension p = 0.006) and walking (Timed 25-ft walk p = 0.01, walk velocity p = 0.008). Strength is the most significant factor affecting change in walk velocity in the regression model including group, disability, and imaging. Pain is the only factor that relates to quality of life, however, post training, improved strength moderates this relationship. Age significantly contributes to weakness in X-linked adrenoleukodystrophy but not to vibratory loss. White matter integrity contributes to models of vibratory loss and predicting walking benefits from exercise.
Interpretation:
This data identifies meaningful outcomes for clinical trials and treatment guidelines for the health of females with X-linked adrenoleukodystrophy. Sensory loss quantification is an important marker of this pathology regardless of age-related changes. Pain significantly impacts quality of life. Importantly, we show that females with X-ALD responded to exercise with improved strength and walking as much as controls, despite starting from a more impaired state.
Related Concept Videos
Alzheimer's Disease: Treatment
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Atherosclerosis III: Management
